Gokmen, A. Et Al. 2022. Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients. Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10 .

Gokmen, A., Sahin, U., Soydan, E., Gokgoz, Z., Okcu, M. K., Ozan, U., ... ARSLAN, Ö.(2022). Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients. Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10.

Gokmen, Ayla Et Al. "Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients," Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10, 2022

Gokmen, Ayla Et Al. "Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients." Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10, 2022

Gokmen, A. Et Al. (2022) . "Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients." Clinical Lymphoma, Myeloma and Leukemia , vol.22, no.10.

@article{article, author={Ayla Gokmen Et Al. }, title={Gemcitabine, Cisplatin, and Dexamethasone as a Salvage and Mobilization Chemotherapy Before Autologous Stem Cell Transplantation is Effective and Safe Outpatient Regimen in Relapsed and Refractory Hodgkin Lymphoma Patients}, journal={Clinical Lymphoma, Myeloma and Leukemia}, year=2022}